<SEC-DOCUMENT>0001169245-21-000074-index.html : 20210810
<SEC-HEADER>0001169245-21-000074.hdr.sgml : 20210810
<ACCEPTANCE-DATETIME>20210810080315
ACCESSION NUMBER:		0001169245-21-000074
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20210810
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210810
DATE AS OF CHANGE:		20210810

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PhaseBio Pharmaceuticals Inc
		CENTRAL INDEX KEY:			0001169245
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				030375697
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38697
		FILM NUMBER:		211158475

	BUSINESS ADDRESS:	
		STREET 1:		1 GREAT VALLEY PARKWAY
		STREET 2:		SUITE 30
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355
		BUSINESS PHONE:		(610) 981-6500

	MAIL ADDRESS:	
		STREET 1:		1 GREAT VALLEY PARKWAY
		STREET 2:		SUITE 30
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Phase Biosciences Inc
		DATE OF NAME CHANGE:	20061013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DT BIOSCIENCES INC
		DATE OF NAME CHANGE:	20020315
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a8-kx81021.htm
<DESCRIPTION>8-K
<TEXT>
Document 1 - file: a8-kx81021.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991-8xkx81021.htm
<DESCRIPTION>EX-99.1
<TEXT>
Document 2 - file: ex991-8xkx81021.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>phasebio2020logo.jpg
<TEXT>
Document 3 - file: phasebio2020logo.jpg

</DOCUMENT>
</SEC-DOCUMENT>